Showing results (401-410 of 1,831) with videos related to

Sort By:
Pageof 184
ESMO Open|September 15, 2023
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across EuropeP Hofman, F Calabrese, I Kern, et al.
ESMO Open|April 1, 2026
Integrating baseline ctDNA-derived tumor metrics enhances risk stratification in HR-positive/HER2-negative advanced breast cancer: a real-world multicenter cohort study from AustriaN Dobrić, S O Hasenleithner, C Suppan, et al.
ESMO Open|April 10, 2026
A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trialG-E Schuebbe, Y Xu, L H Lindner, et al.
ESMO Open|March 27, 2026
Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort studyF Moik, F Huemer, B Doleschal, et al.
ESMO Open|April 1, 2026
Comparative efficacy of zanubrutinib plus obinutuzumab versus last prior treatment in relapsed/refractory follicular lymphoma: growth modulation index analysis from the ROSEWOOD studyJ Trotman, K Bouabdallah, F Bijou, et al.
ESMO Open|May 1, 2026
Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitorsJ Ros, M C de Grandis, V Navarro, et al.
ESMO Open|June 10, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysisA Raimondi, G Tinè, V Boige, et al.
ESMO Open|June 25, 2019
Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia surveyChi Kong Li, Rashmi Dalvi, Kan Yonemori, et al.
ESMO Open|July 10, 2026
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners FoundationS Peters, M-L Meyer, F André, et al.
ESMO Open|June 30, 2026
ELECLA trial: final results of perioperative chemotherapy with fluoropyrimidine and oxaliplatin in mismatch repair proficient locally advanced colon cancerJ Arredondo, D Aliseda, C Castañón, et al.
Pageof 184